MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Featured in Benzinga Article Evaluating Potential of Cannabinoids in Treating Alzheimer’s
On Thursday, India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, was featured in an article on Benzinga titled ‘Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work’. The article notes that soon after discovering the pathway by which low-dose THC binds to amyloid beta plaques and prevents them from aggregating on neurons, the University of South Florida filed a patent for that mechanism. Notably, IGC announced on June 12 that it had acquired exclusive rights to this patent, titled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’, positioning the company to protect a potential cannabis-based blockbuster treatment for America’s most expensive disease. “What IGC is going to do with this patent is take it to clinical trials,” Ram Mukunda, CEO of IGC, stated in the Benzinga article. “We have productized it, and there is more than sufficient evidence. So, now we are now talking to several different places to see where we can begin clinical testing on the path to FDA approval.” If FDA approval is achieved, the market potential for a THC-based Alzheimer’s treatment could be expansive. There are currently more than 5.3 million Americans living with Alzheimer’s, and Medicare and Medicaid alone are expected to spend $175 billion on Alzheimer’s patients in 2017.
To view the full Benzinga article, visit http://dtn.fm/WuNY5
About IGC
India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Friday, June 30, 2017
Thursday, June 29, 2017
Net Element’s (NASDAQ: NETE) North American Business Up 40 Percent in First Quarter
- North American business up 40 percent in Q1
- Track record of phenomenal domestic growth with international growth plan in place
- Zach’s pegs NETE at $3.12 per share once profitable
Currently trading at 65 cents a share, Zach’s Small Cap Research just pegged Net Element (NASDAQ: NETE) at $3.12, five times current market value, once it reaches profitability (http://dtn.fm/9vNVT). The highly respected research firm noted that Net Element’s U.S. business growth was up a phenomenal 40 percent in the first quarter, while the company’s overseas operations and expansion were currently dragging down growth. However, global expansion has been a cornerstone of Net Element’s long term growth plans.
Growth, the elixir of Wall Street, is no stranger to Net Element. Just last year, the company was recognized by the South Florida Business Journal as one of the fastest growing technology companies in the United States, and, in 2012, the company’s Unified Payments division was named the fastest-growing private company in America by Inc. Magazine. To become an industry leader, investing, opening and expanding into new markets is imperative to sustain growth trajectories over time.
A technology-driven mobile payments and transactional services company, Net Element’s products and services include mobile payments, value-added services, marketing solutions and business analytics. Through its wholly owned group of companies, Net Element’s global divisions support electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company provides turn-key services, including the technology and services required for cashless transactions, to small and medium-sized businesses throughout the United States and in select international markets.
Known for its dynamic marketing efforts, Net Element’s North American Unified Payments division continued its strong growth in Q1 2017 as the company added a record 1,500 merchants to its customer base. The company is aggressively adding new North American customers, and rapid customer acquisition is continuing into Q2.
Net Element’s international game plan is to spur global growth where it already has a substantial footprint by leveraging its omni-channel platform to deliver flexible offerings to select emerging markets with diverse banking, regulatory and demographic conditions, such as the UAE, Kazakhstan, Kyrgyzstan and Azerbaijan. Net Element has already launched initiatives is these locations.
Given Net Element’s historic track record of phenomenal domestic growth, there’s no reason to doubt the company’s ability to grow internationally. Once Net Element kicks revenue in its international markets into high gear, profitability should be around the corner and Zach’s target of $3.12 per share should easily be in reach.
For more information, visit www.NetElement.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
- Track record of phenomenal domestic growth with international growth plan in place
- Zach’s pegs NETE at $3.12 per share once profitable
Currently trading at 65 cents a share, Zach’s Small Cap Research just pegged Net Element (NASDAQ: NETE) at $3.12, five times current market value, once it reaches profitability (http://dtn.fm/9vNVT). The highly respected research firm noted that Net Element’s U.S. business growth was up a phenomenal 40 percent in the first quarter, while the company’s overseas operations and expansion were currently dragging down growth. However, global expansion has been a cornerstone of Net Element’s long term growth plans.
Growth, the elixir of Wall Street, is no stranger to Net Element. Just last year, the company was recognized by the South Florida Business Journal as one of the fastest growing technology companies in the United States, and, in 2012, the company’s Unified Payments division was named the fastest-growing private company in America by Inc. Magazine. To become an industry leader, investing, opening and expanding into new markets is imperative to sustain growth trajectories over time.
A technology-driven mobile payments and transactional services company, Net Element’s products and services include mobile payments, value-added services, marketing solutions and business analytics. Through its wholly owned group of companies, Net Element’s global divisions support electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company provides turn-key services, including the technology and services required for cashless transactions, to small and medium-sized businesses throughout the United States and in select international markets.
Known for its dynamic marketing efforts, Net Element’s North American Unified Payments division continued its strong growth in Q1 2017 as the company added a record 1,500 merchants to its customer base. The company is aggressively adding new North American customers, and rapid customer acquisition is continuing into Q2.
Net Element’s international game plan is to spur global growth where it already has a substantial footprint by leveraging its omni-channel platform to deliver flexible offerings to select emerging markets with diverse banking, regulatory and demographic conditions, such as the UAE, Kazakhstan, Kyrgyzstan and Azerbaijan. Net Element has already launched initiatives is these locations.
Given Net Element’s historic track record of phenomenal domestic growth, there’s no reason to doubt the company’s ability to grow internationally. Once Net Element kicks revenue in its international markets into high gear, profitability should be around the corner and Zach’s target of $3.12 per share should easily be in reach.
For more information, visit www.NetElement.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Poised to Benefit from Significant Shifts in China’s Economy
China is rapidly gaining on the United States’ leading position as the world’s largest economy, and Moxian, Inc. (NASDAQ: MOXC) is poised to profit from the impending economic transition by leveraging a unique platform that converts online users to retail customers. “Today, China’s economy is the second-largest in the world and is likely to overtake the U.S. sometime this century. The country is in the process of transforming itself from a global center of low-tech manufacturing into a major hub of innovation and consumption … To capture the immense new opportunities in China’s changing consumer market, companies must become more strategic in targeting income segments, product categories, and retail channels. To succeed, it’s imperative that companies take into account rapid shifts in consumer consumption patterns. Serving the businesses that feed Chinese consumer demand, Moxian, Inc. (NASDAQ: MOXC) is poised to profit from the long and vast economic transition in China. Moxian provides small and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online to brick and mortar business customers.”
To view the full article, visit: http://dtn.fm/DG2zW
About Moxian, Inc.
Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. More information about the company can be found at www.Moxian.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full article, visit: http://dtn.fm/DG2zW
About Moxian, Inc.
Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. More information about the company can be found at www.Moxian.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, June 28, 2017
India Globalization Capital, Inc. (NYSE: IGC) at the Threshold of a Potential Alzheimer’s Breakthrough
Alzheimer’s is the most ominous and expensive disease in the U.S.
IGC is the first and only NYSE MKT-listed pharmaceutical company to develop cannabis-based Alzheimer’s therapies
IGC’s patent pending phytocannabinoid therapies to enter clinical trials for potential Alzheimer’s breakthrough
A pioneer in the development of innovative cannabis-based combination therapies, India Globalization Capital (NYSE MKT: IGC) is creating new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of patent pending therapeutics include treatments for pain, cachexia, neurologic disorders, Parkinson’s and Alzheimer’s disease. IGC plans to enter clinical trials this year on its primary pipeline of four major therapeutics that address large market maladies. These trials include a potential cannabis-based blockbuster treatment for Alzheimer’s, America’s most ominous and expensive disease.
Alzheimer’s disease has no cure, no means of prevention and no long-term disease-modifying treatments. It’s a fatal, progressive brain disease that slowly destroys memory and thinking skills. It’s the third-leading cause of death in the U.S., following cancer and heart disease. More than 5.3 million Americans and over 46 million people worldwide are currently suffering from Alzheimer’s, and, frighteningly, this number is expected to triple within a few decades. Alzheimer’s is also the most expensive disease in the nation. In 2016, costs totaled $236 billion for the U.S., and global costs exceeded $600 billion. These figures will skyrocket if the disease continues unchecked.
Bolstering its portfolio of patent pending cannabis-based pharmaceuticals, IGC recently acquired exclusive rights to a novel THC-based treatment for Alzheimer’s disease from the University of South Florida (http://www.igcinc.us/alzheimers-disease/). Under the definitive license agreement with the university, IGC is the exclusive licensee of a patent filing for the use of tetrahydrocannabinol (THC) as a potential therapeutic agent for Alzheimer’s. The patent claims discovery of a new pathway in which low doses of THC bind to amyloid beta plaques and prevent those plaques from aggregating on neurons, which is exactly what occurs in Alzheimer’s disease and causes cognitive decline.
This new pathway holds immense potential in treating Alzheimer’s, and IGC will own the rights to this unprecedented therapeutic pathway if the patent is granted and proven. Acquiring this patent further supports IGC in protecting its proprietary formulation IGC-AD1, which includes low-doses of THC and is intended to disrupt the buildup of amyloid beta plaques and alleviate some of the worst symptoms of Alzheimer’s disease.
Several clinical studies are currently underway to address the ravages of Alzheimer’s, but later this year IGC will become the first and only company to utilize cannabis-based therapies for the treatment of the disease. Even though there are about a dozen publicly traded cannabis pharmaceutical stocks on the market, none have patent filings to a potential Alzheimer’s breakthrough.
Should IGC’s clinical studies show promise on Alzheimer’s or any of its primary pipeline of phytocannabinoid therapeutics, it could not only trigger a major shift in national medical marijuana policy but also dramatically impact the company’s market capitalization and stock price to the upside.
For more information, please visit http://www.igcinc.us
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
IGC is the first and only NYSE MKT-listed pharmaceutical company to develop cannabis-based Alzheimer’s therapies
IGC’s patent pending phytocannabinoid therapies to enter clinical trials for potential Alzheimer’s breakthrough
A pioneer in the development of innovative cannabis-based combination therapies, India Globalization Capital (NYSE MKT: IGC) is creating new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of patent pending therapeutics include treatments for pain, cachexia, neurologic disorders, Parkinson’s and Alzheimer’s disease. IGC plans to enter clinical trials this year on its primary pipeline of four major therapeutics that address large market maladies. These trials include a potential cannabis-based blockbuster treatment for Alzheimer’s, America’s most ominous and expensive disease.
Alzheimer’s disease has no cure, no means of prevention and no long-term disease-modifying treatments. It’s a fatal, progressive brain disease that slowly destroys memory and thinking skills. It’s the third-leading cause of death in the U.S., following cancer and heart disease. More than 5.3 million Americans and over 46 million people worldwide are currently suffering from Alzheimer’s, and, frighteningly, this number is expected to triple within a few decades. Alzheimer’s is also the most expensive disease in the nation. In 2016, costs totaled $236 billion for the U.S., and global costs exceeded $600 billion. These figures will skyrocket if the disease continues unchecked.
Bolstering its portfolio of patent pending cannabis-based pharmaceuticals, IGC recently acquired exclusive rights to a novel THC-based treatment for Alzheimer’s disease from the University of South Florida (http://www.igcinc.us/alzheimers-disease/). Under the definitive license agreement with the university, IGC is the exclusive licensee of a patent filing for the use of tetrahydrocannabinol (THC) as a potential therapeutic agent for Alzheimer’s. The patent claims discovery of a new pathway in which low doses of THC bind to amyloid beta plaques and prevent those plaques from aggregating on neurons, which is exactly what occurs in Alzheimer’s disease and causes cognitive decline.
This new pathway holds immense potential in treating Alzheimer’s, and IGC will own the rights to this unprecedented therapeutic pathway if the patent is granted and proven. Acquiring this patent further supports IGC in protecting its proprietary formulation IGC-AD1, which includes low-doses of THC and is intended to disrupt the buildup of amyloid beta plaques and alleviate some of the worst symptoms of Alzheimer’s disease.
Several clinical studies are currently underway to address the ravages of Alzheimer’s, but later this year IGC will become the first and only company to utilize cannabis-based therapies for the treatment of the disease. Even though there are about a dozen publicly traded cannabis pharmaceutical stocks on the market, none have patent filings to a potential Alzheimer’s breakthrough.
Should IGC’s clinical studies show promise on Alzheimer’s or any of its primary pipeline of phytocannabinoid therapeutics, it could not only trigger a major shift in national medical marijuana policy but also dramatically impact the company’s market capitalization and stock price to the upside.
For more information, please visit http://www.igcinc.us
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – SRAX (NASDAQ: SRAX) Announces New Tool Aimed at Extending the Reach of Facebook Posts
Internet advertising company SRAX (NASDAQ: SRAX) this morning announced the launch of a new SRAX Social tool for digital marketers and content owners designed to create and promote posts that extend beyond their Facebook page communities. This release is noteworthy as, according to industry reporting, organic reach for businesses on Facebook fell more than 50 percent last year. “Organic reach for brand content on Facebook has rapidly declined leading to strong demand to boost content on the social network and beyond,” Chris Miglino, CEO and chairman of SRAX, stated in the news release. “The ability to boost posts directly from SRAX Social provides digital marketers and content owners a new tool to take advantage of the paid media opportunities on Facebook, while managing social media efforts, most importantly, data across social channels and campaigns, through one platform.” The new tool is the first of many planned monetization opportunities to be integrated into SRAX’s social media management platform, SRAX Social, which leverages programmatic technology and big data to share, schedule and automate social media content.
To view the full press release, visit http://dtn.fm/Fm8hF
About SRAX
SRAX (NASDAQ: SRAX) is an advertising technology company providing the tools to automate digital marketers and content owners’ campaigns across digital channels. SRAX’s tools amplify performance and maximize profits for brands in the healthcare, CPG, automotive, wellness and lifestyle verticals through an omnichannel approach that integrates all aspects of the marketing experience into one platform. The company’s machine-learning technology identifies brands’ core consumers and their characteristics discovering new and measurable opportunities to target, reach and monetize audiences driving online and offline sales lift. For more information on how SRAX delivers a digital competitive advantage to surpass today’s marketing challenges, visit www.srax.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/Fm8hF
About SRAX
SRAX (NASDAQ: SRAX) is an advertising technology company providing the tools to automate digital marketers and content owners’ campaigns across digital channels. SRAX’s tools amplify performance and maximize profits for brands in the healthcare, CPG, automotive, wellness and lifestyle verticals through an omnichannel approach that integrates all aspects of the marketing experience into one platform. The company’s machine-learning technology identifies brands’ core consumers and their characteristics discovering new and measurable opportunities to target, reach and monetize audiences driving online and offline sales lift. For more information on how SRAX delivers a digital competitive advantage to surpass today’s marketing challenges, visit www.srax.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Tuesday, June 27, 2017
Moxian, Inc. (NASDAQ: MOXC) Poised to Profit from China’s Transformation
China’s economy is now world’s 2nd largest – set to overtake the U.S. this century
695 million+ mobile internet users create new Chinese consumer
Moxian, Inc. (NASDAQ: MOXC) platforms convert online users to retail customers
The roots of modern capitalist China are curiously and inexorably linked to the 1949 foundation of the People’s Republic of China by communist revolutionary Mao Zedong. In spite of horrific atrocities, Mao is still credited for modernizing China and building it into a world power as China’s population grew from around 550 million to over 900 million under his leadership. Mao seized control of China after a brutal civil war and held power until his death in 1976. Many of his socialist policies such as promoting the status of women, improving education and health care, and increasing life expectancy actually integrate and underpin today’s Chinese economic model. Since inception, the People’s Republic of China has surreptitiously and steadily embraced the tenets of capitalism, especially since economic reforms were enacted in 1978.
Succeeding Mao, Deng Xiaoping, a Communist Party veteran, was eager to adopt capitalist methods and reforms to try to stimulate economic growth and restore confidence in the party. Deng launched several economic reforms that allowed private sectors to start and operate their own businesses again. He also established four special economic zones along the coast of China with intentions of attracting foreign investments. Due to the reforms Deng put in place, China has gone from being a country that opposed capitalism to one that embraces property rights, profits and free market competition.
Today, China’s economy is the second-largest in the world and is likely to overtake the U.S. sometime this century. The country is in the process of transforming itself from a global center of low-tech manufacturing into a major hub of innovation and consumption.
Computer usage in China has exploded. There are now over 730 million internet users in China and over 95 percent, 695 million+, use mobile devices for internet access. This massive increase of computer users in China creates both challenges and opportunities.
To capture the immense new opportunities in China’s changing consumer market, companies must become more strategic in targeting income segments, product categories, and retail channels. To succeed, it’s imperative that companies take into account rapid shifts in consumer consumption patterns. Serving the businesses that feed Chinese consumer demand, Moxian, Inc. (NASDAQ: MOXC) is poised to profit from the long and vast economic transition in China.
Moxian provides small and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online to brick and mortar business customers. Moxian operates a captivating social network which integrates social media and business into a single platform that offers products, features and services that appeal to consumers, keeping them engaged, coming back and even referring new customers.
The company’s online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both existing and new customers. These interactions provide each business the data to analyze consumer likes, dislikes and trends. Moxian’s platform gives businesses the ability to create, manage and promote individualized customer loyalty programs, targeted advertising campaigns and special promotions. These interactions between users and Moxian’s merchant clients give businesses the ability to study consumer behavior and tailor offerings to customers. Moxian is leveraging technology to drive business in the new Chinese consumer economy and offers an opportunity to profit from China’s transformation from communism to consumerism.
For more information, visit www.Moxian.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
695 million+ mobile internet users create new Chinese consumer
Moxian, Inc. (NASDAQ: MOXC) platforms convert online users to retail customers
The roots of modern capitalist China are curiously and inexorably linked to the 1949 foundation of the People’s Republic of China by communist revolutionary Mao Zedong. In spite of horrific atrocities, Mao is still credited for modernizing China and building it into a world power as China’s population grew from around 550 million to over 900 million under his leadership. Mao seized control of China after a brutal civil war and held power until his death in 1976. Many of his socialist policies such as promoting the status of women, improving education and health care, and increasing life expectancy actually integrate and underpin today’s Chinese economic model. Since inception, the People’s Republic of China has surreptitiously and steadily embraced the tenets of capitalism, especially since economic reforms were enacted in 1978.
Succeeding Mao, Deng Xiaoping, a Communist Party veteran, was eager to adopt capitalist methods and reforms to try to stimulate economic growth and restore confidence in the party. Deng launched several economic reforms that allowed private sectors to start and operate their own businesses again. He also established four special economic zones along the coast of China with intentions of attracting foreign investments. Due to the reforms Deng put in place, China has gone from being a country that opposed capitalism to one that embraces property rights, profits and free market competition.
Today, China’s economy is the second-largest in the world and is likely to overtake the U.S. sometime this century. The country is in the process of transforming itself from a global center of low-tech manufacturing into a major hub of innovation and consumption.
Computer usage in China has exploded. There are now over 730 million internet users in China and over 95 percent, 695 million+, use mobile devices for internet access. This massive increase of computer users in China creates both challenges and opportunities.
To capture the immense new opportunities in China’s changing consumer market, companies must become more strategic in targeting income segments, product categories, and retail channels. To succeed, it’s imperative that companies take into account rapid shifts in consumer consumption patterns. Serving the businesses that feed Chinese consumer demand, Moxian, Inc. (NASDAQ: MOXC) is poised to profit from the long and vast economic transition in China.
Moxian provides small and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online to brick and mortar business customers. Moxian operates a captivating social network which integrates social media and business into a single platform that offers products, features and services that appeal to consumers, keeping them engaged, coming back and even referring new customers.
The company’s online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both existing and new customers. These interactions provide each business the data to analyze consumer likes, dislikes and trends. Moxian’s platform gives businesses the ability to create, manage and promote individualized customer loyalty programs, targeted advertising campaigns and special promotions. These interactions between users and Moxian’s merchant clients give businesses the ability to study consumer behavior and tailor offerings to customers. Moxian is leveraging technology to drive business in the new Chinese consumer economy and offers an opportunity to profit from China’s transformation from communism to consumerism.
For more information, visit www.Moxian.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, June 21, 2017
Crexendo’s (CXDO) Revolutionary Cloud-Based Phone Systems Let Businesses ‘Cut the Cord’ Between Offices and the Outside World
Offering high-quality voice, data, and marketing solutions that help businesses focus on their core operations, Crexendo, Inc. (OTCQX: CXDO) is a competitive local exchange carrier (CLEC) cloud services company that offers award-winning cloud telecommunications, broadband Internet, and other cloud business services. The company provides critical voice and data technology infrastructure for startups, small and medium-sized business (SMB), and small enterprise markets, offering enterprise-caliber cloud services at affordable monthly rates. The company’s world-class services help businesses significantly increase their productivity, and Crexendo is payment card industry-compliant and CLEC-licensed for its cloud web, telecommunications, and network services.
Guided by a team of industry leaders, Crexendo is dedicated to maintaining secure and reliable cloud systems. Beginning with a cutting-edge data center that has multiple redundancy levels and the very best security defenses, Crexendo epitomizes the very highest standards of security and reliability.
Crexendo’s cloud-based phone systems transcend standard phone systems, providing businesses with advanced calling features that cost significantly less. Businesses get the features they need and a full array of productive telecommunication tools, but in the cloud and at a lower price point.
Through Crexendo Mobile, businesses are able to revolutionize their productivity with a simple download. Crexendo Mobile enables businesspeople to access all the features of their office phone right on their existing mobile device, which lets them seamlessly continue their business communications from office to home and everywhere in-between. Crexendo Mobile can also be downloaded to other wireless devices, including tablets. Crexendo Mobile lets individuals make and take calls using their office phone number, showing that office number as their caller ID. This innovative solution additionally separates business voicemails from personal messages and lets users listen to business-related voice messages in any order via visual voicemail. Users can view call times, call dates, and make return phone calls using Crexendo call logs, and calls can be made via 3G/4G networks so that monthly cell phone minutes aren’t impacted. What’s more, Crexendo lets businesspeople traveling internationally call the United States for free using CrexMo.
Crexendo’s cutting-edge solutions give businesses unparalleled freedom, cutting the cord between the office and the outside world and improving productivity like never before.
For more information, visit the company’s website at www.Crexendo.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Guided by a team of industry leaders, Crexendo is dedicated to maintaining secure and reliable cloud systems. Beginning with a cutting-edge data center that has multiple redundancy levels and the very best security defenses, Crexendo epitomizes the very highest standards of security and reliability.
Crexendo’s cloud-based phone systems transcend standard phone systems, providing businesses with advanced calling features that cost significantly less. Businesses get the features they need and a full array of productive telecommunication tools, but in the cloud and at a lower price point.
Through Crexendo Mobile, businesses are able to revolutionize their productivity with a simple download. Crexendo Mobile enables businesspeople to access all the features of their office phone right on their existing mobile device, which lets them seamlessly continue their business communications from office to home and everywhere in-between. Crexendo Mobile can also be downloaded to other wireless devices, including tablets. Crexendo Mobile lets individuals make and take calls using their office phone number, showing that office number as their caller ID. This innovative solution additionally separates business voicemails from personal messages and lets users listen to business-related voice messages in any order via visual voicemail. Users can view call times, call dates, and make return phone calls using Crexendo call logs, and calls can be made via 3G/4G networks so that monthly cell phone minutes aren’t impacted. What’s more, Crexendo lets businesspeople traveling internationally call the United States for free using CrexMo.
Crexendo’s cutting-edge solutions give businesses unparalleled freedom, cutting the cord between the office and the outside world and improving productivity like never before.
For more information, visit the company’s website at www.Crexendo.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Monday, June 19, 2017
Nasdaq and Bats Square off on Market-Close Orders
The status quo never likes change, nor the upstarts that attempt to initiate innovation. When innovation and change occur, the entrenched typically lose prominence, certainly preeminence, and often times money. Disagreement and conflict ensue, but the strongest survive and seem to stay in power. It happens across the full spectrum of businesses, and it’s happening again now with Nasdaq, Inc. and Bats Global Markets.
Most are familiar with Nasdaq, the world’s first electronic stock market. It was founded in 1971 by the National Association of Securities Dealers, the financial self-regulatory agency of its era. At first, Nasdaq was only a quotation system, but, eventually, it effectuated the majority of trades that previously had been executed through the over-the-counter system where trades between parties occurred without exchange supervision. Over time, Nasdaq helped lower the bid-ask spread in stocks and became more of a true stock exchange by adding trade and volume reporting and automated trading systems. It was the first stock exchange to start online trading and touted itself as “the stock market for the next hundred years“. A hundred year superiority was not in the cards, but Nasdaq did attract new growth companies such as Microsoft, Oracle, Apple, and Cisco, and it helped modernize the IPO process. In 1992, Nasdaq merged with the London Stock Exchange and formed the first globally linked markets. In 2000, it was spun off and went public as an independent exchange and was licensed as a national securities exchange in 2006, about the time its claim of a one-hundred year reign was being challenged.
Bats Global Markets was founded in June 2005 by a computer programmer, Dave Cummings, after watching the consolidation and monopolization of the exchanges by the NYSE and Nasdaq. Cummings publicized the Bats service by sending solicitation emails to companies highlighting the benefits of trading on platforms other than the NYSE or Nasdaq, which had eliminated competition and raised prices for their services. The Bats system charged less, which helped attract other brokerage firms and hedge funds to engage with the upstart trading system. In 2008, Bats entered the European equities markets to compete against global incumbent securities exchanges. Bats tried to go public in 2012 but withdrew due to a calamitous trading system glitch and admitted what it called a system issue. In March of 2017, Bats was acquired by CBOE Holdings, the owner of the Chicago Board Options Exchange, for $3.2 billion. Established in 1973, the CBOE is the largest options exchange in the U.S., and the acquisition of Bats put the CBOE in direct competition with Nasdaq and the NYSE.
The latest contest between these trading behemoths centers on Bats wanting to offer brokers a type of order that would give them the same closing prices derived from the closing auctions on Nasdaq and the New York Stock Exchange for stocks listed on those exchanges, but with lower execution fees. Nasdaq said in a letter to the U.S. Securities and Exchange Commission that such a move by Bats, which currently only lists ETFs and the stock of its parent company, CBOE Holdings, would fragment the market close and result in less accurate pricing. NYSE has also blasted the Bats proposal, saying that diverting trades away from closing auctions would add to volatility and distort prices. (http://www.reuters.com/article/us-nasdaq-bats-marketclose-idUSKBN1942GM?utm_source=applenews)
This is a turf war among giants and one can only believe that whoever wins and becomes dominant will adjust prices to their own benefit. Meet the new boss, same as the old boss.
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Most are familiar with Nasdaq, the world’s first electronic stock market. It was founded in 1971 by the National Association of Securities Dealers, the financial self-regulatory agency of its era. At first, Nasdaq was only a quotation system, but, eventually, it effectuated the majority of trades that previously had been executed through the over-the-counter system where trades between parties occurred without exchange supervision. Over time, Nasdaq helped lower the bid-ask spread in stocks and became more of a true stock exchange by adding trade and volume reporting and automated trading systems. It was the first stock exchange to start online trading and touted itself as “the stock market for the next hundred years“. A hundred year superiority was not in the cards, but Nasdaq did attract new growth companies such as Microsoft, Oracle, Apple, and Cisco, and it helped modernize the IPO process. In 1992, Nasdaq merged with the London Stock Exchange and formed the first globally linked markets. In 2000, it was spun off and went public as an independent exchange and was licensed as a national securities exchange in 2006, about the time its claim of a one-hundred year reign was being challenged.
Bats Global Markets was founded in June 2005 by a computer programmer, Dave Cummings, after watching the consolidation and monopolization of the exchanges by the NYSE and Nasdaq. Cummings publicized the Bats service by sending solicitation emails to companies highlighting the benefits of trading on platforms other than the NYSE or Nasdaq, which had eliminated competition and raised prices for their services. The Bats system charged less, which helped attract other brokerage firms and hedge funds to engage with the upstart trading system. In 2008, Bats entered the European equities markets to compete against global incumbent securities exchanges. Bats tried to go public in 2012 but withdrew due to a calamitous trading system glitch and admitted what it called a system issue. In March of 2017, Bats was acquired by CBOE Holdings, the owner of the Chicago Board Options Exchange, for $3.2 billion. Established in 1973, the CBOE is the largest options exchange in the U.S., and the acquisition of Bats put the CBOE in direct competition with Nasdaq and the NYSE.
The latest contest between these trading behemoths centers on Bats wanting to offer brokers a type of order that would give them the same closing prices derived from the closing auctions on Nasdaq and the New York Stock Exchange for stocks listed on those exchanges, but with lower execution fees. Nasdaq said in a letter to the U.S. Securities and Exchange Commission that such a move by Bats, which currently only lists ETFs and the stock of its parent company, CBOE Holdings, would fragment the market close and result in less accurate pricing. NYSE has also blasted the Bats proposal, saying that diverting trades away from closing auctions would add to volatility and distort prices. (http://www.reuters.com/article/us-nasdaq-bats-marketclose-idUSKBN1942GM?utm_source=applenews)
This is a turf war among giants and one can only believe that whoever wins and becomes dominant will adjust prices to their own benefit. Meet the new boss, same as the old boss.
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Friday, June 16, 2017
MissionIRNewsBreaks – Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Offers Update on Sully Project Exploration
Mineral exploration and development company Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) this morning issued an update on its exploration activities and upcoming drill testing at the Sully project. Notably, field programs have continued through May and early June with a specific focus on the company’s E3 target, including detailed gravity surveying, interpretation and mass modeling, prospecting and mapping, soil geochemistry sampling, drilling preparations and road/access preparations. Excel Geophysics recently completed interpretation and mass modeling of this new data, identifying a “well-defined, sizeable and discreet anomaly at this target location.” Brian Jones, principle of Excel Geophysics, noted E3’s attractiveness as a drilling target in the news release. “E3 has emerged as a strong geophysical target,” he stated. “Now it needs to be tested.” Per the update, a drill site at the E3 target has already been identified, and preparations are currently underway to mobilize FB Drilling of Cranbrook, British Columbia, in order to identify the source of the gravity anomalies.
To view the full press release, visit http://dtn.fm/QRzo7
About Kootenay Zinc Corp.
Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The Company is focused on discovering large-scale sedimentary-exhalative (“SEDEX”) deposits. The Sully Property comprises 1,375 hectares located approximately 30 kilometres (18 miles) east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property. For more information visit www.kootenayzinc.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/QRzo7
About Kootenay Zinc Corp.
Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The Company is focused on discovering large-scale sedimentary-exhalative (“SEDEX”) deposits. The Sully Property comprises 1,375 hectares located approximately 30 kilometres (18 miles) east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property. For more information visit www.kootenayzinc.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Thursday, June 15, 2017
PV Nano Cell (PVNNF) Increases IP War Chest as Japanese Patent Office Grants Silver Nano Particles Patent for 3D Printing
A recent Forbes (http://dtn.fm/2WfWR) article shows just how far Additive Manufacturing (AM), a.k.a. 3D Printing, has come, reporting that the government of Dubai, United Arab Emirates, ‘has set a target for 25 percent of buildings to be 3D-printed by 2030.’ Apparently, the AM industry now believes it has the technology to “print” houses. That technological prowess also appears to extend to smaller objects, much smaller, where the challenges are different but just as formidable. An Economist feature (http://dtn.fm/71FDh) tells how a Chinese contract manufacturer is using 3D printers ‘to print electronic circuits, such as antennae and sensors, directly into products instead of making those components separately and assembling them into the devices.’ Printers need ink, however, and 3D printers need the special kind produced by PV Nano Cell (OTCQB: PVNNF). Under the Sicrys™ brand, the innovative Israeli outfit has developed a menu of customized single crystal nanometric conductive inks for use in the manufacture of a wide range of electronic devices.
The devices that PVNNF’s inks are designed to work with are less than Lilliputian. A nanometer is one-billionth of a meter or, put another way, it would take 25,400,000 nanometers in a line to cover a distance of just one inch. These tiny devices are, more often than not, required to transmit electrical signals and, consequently, need conductive inks of quality. Sicrys™ inks serve a wide range of applications that demand high-performance conductive inks, including mass produced printed electronics applications such as printed circuit boards, antennas, sensors, and touch screens, as well as photovoltaic applications, and are available in both silver-based and copper-based formulations.
PVNNF is bolstering its intellectual property (IP) war chest with a plethora of patents. In May 2017, the company announced (http://dtn.fm/xVPO4) that the Japanese Patent Office (JPO) had granted its silver nano particles patent. The company has already been granted patents in four countries for its silver single crystal nano particles based dispersions and inks and has submitted patents related to its silver and copper nano particles in nine other countries. To date, PVNNF has submitted patent applications for both its silver and copper nano particles in Brazil, China, Europe, India, Israel, Japan, Russia, South Korea, the United Kingdom and the U.S.
Owing to its general applicability, the Sicrys™ portfolio of conductive inks is appearing in many potentially lucrative market segments. For example, the market for “printing” antennas is about $0.5 billion, while for photovoltaic (PV) metallization it’s about $1.8 billion. For flexible and customized electronics, market size is estimated at around $2.0 billion, and for printed circuit boards (PCB) it is about $6.0 billion. The inks are already in use. Albuquerque, New Mexico-based Optomec prints antennas for the mobile industry using Sicrys™ inks, and Stratasys, a pioneer in developing 3D printing technologies, uses Sicrys™ too, as does inkjet technology provider Pixdro.
In the world of 3D printing, PV Nano Cell’s Sicrys™ ink family is hot off the press. The company continues its quest to develop the very best conductive inks for use in solar PV and printed electronics applications.
For more information, please visit www.PVNanoCell.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
The devices that PVNNF’s inks are designed to work with are less than Lilliputian. A nanometer is one-billionth of a meter or, put another way, it would take 25,400,000 nanometers in a line to cover a distance of just one inch. These tiny devices are, more often than not, required to transmit electrical signals and, consequently, need conductive inks of quality. Sicrys™ inks serve a wide range of applications that demand high-performance conductive inks, including mass produced printed electronics applications such as printed circuit boards, antennas, sensors, and touch screens, as well as photovoltaic applications, and are available in both silver-based and copper-based formulations.
PVNNF is bolstering its intellectual property (IP) war chest with a plethora of patents. In May 2017, the company announced (http://dtn.fm/xVPO4) that the Japanese Patent Office (JPO) had granted its silver nano particles patent. The company has already been granted patents in four countries for its silver single crystal nano particles based dispersions and inks and has submitted patents related to its silver and copper nano particles in nine other countries. To date, PVNNF has submitted patent applications for both its silver and copper nano particles in Brazil, China, Europe, India, Israel, Japan, Russia, South Korea, the United Kingdom and the U.S.
Owing to its general applicability, the Sicrys™ portfolio of conductive inks is appearing in many potentially lucrative market segments. For example, the market for “printing” antennas is about $0.5 billion, while for photovoltaic (PV) metallization it’s about $1.8 billion. For flexible and customized electronics, market size is estimated at around $2.0 billion, and for printed circuit boards (PCB) it is about $6.0 billion. The inks are already in use. Albuquerque, New Mexico-based Optomec prints antennas for the mobile industry using Sicrys™ inks, and Stratasys, a pioneer in developing 3D printing technologies, uses Sicrys™ too, as does inkjet technology provider Pixdro.
In the world of 3D printing, PV Nano Cell’s Sicrys™ ink family is hot off the press. The company continues its quest to develop the very best conductive inks for use in solar PV and printed electronics applications.
For more information, please visit www.PVNanoCell.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wait No More, Travelers: Monaker Group’s (MKGI) NextTrip Website Provides Instant Confirmation Service for ALR Users
When a would-be traveler is booking a trip, the last thing they want to do is wait around for hours or even days for the owner of an alternative lodging rental (ALR) to get back to them and confirm a booking of the property. Streamlining the travel booking process like never before, Monaker Group’s (OTCQB: MKGI) proprietary booking engine has solved one of the travel industry’s most frustrating problems: lack of access to instant booking confirmation for ALRs. The company is rolling out the technology with “white label” B2B integrations into main stream travel channels.
Hotel websites have long offered instant booking, letting travelers immediately see and have confirmation that they have successfully booked a hotel stay. However, for ALR properties, which include private vacation homes, apartments, condos, chalets, villas and even castles, those wishing to book a stay have been at the mercy of property owners to get back to them before they could complete a booking. Monaker has done away with that waiting game, however — much to the delight of travelers everywhere.
Monaker’s recently launched NextTrip website and accompanying NextTrip mobile app have solved the issue of ALR booking delays, providing users with a huge selection of instantly bookable ALR property choices throughout the world — instant confirmation, no waiting! NextTrip also lets users book other major travel services while they’re shopping for ALR properties, including conventional hotels, airlines, car rentals and tour packages, making NextTrip a true one-stop shop for travelers everywhere. In all, the NextTrip website and mobile app list over 1.2 million instantly bookable ALR properties along with 200,000 hotels, 400 airlines, every major rental car company and 10,000 activities for tourists.
The Monaker Booking Engine (MBE), a new cloud-based technology platform, powers NextTrip, delivering Monaker’s worldwide ALR inventory through a flexible API that also supports the distribution of the company’s ALR products to B2B travel industry partners. The company’s MBE and API have been built to the very latest industry standards, enabling customer integration into virtually any existing travel booking system.
ALR is one of the fastest growing sectors in the travel industry and is projected to grow at more than seven percent CAGR to reach $194 billion by 2021. The global online travel market is expected to reach $1,091 billion by 2022, according to a recent report from Allied Market Research. Monaker is seeking to capitalize on these incredible growth projections as it meets the rapidly increasing demand for easily bookable alternative lodging.
For more information, visit www.MonakerGroup.com or www.NextTrip.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Hotel websites have long offered instant booking, letting travelers immediately see and have confirmation that they have successfully booked a hotel stay. However, for ALR properties, which include private vacation homes, apartments, condos, chalets, villas and even castles, those wishing to book a stay have been at the mercy of property owners to get back to them before they could complete a booking. Monaker has done away with that waiting game, however — much to the delight of travelers everywhere.
Monaker’s recently launched NextTrip website and accompanying NextTrip mobile app have solved the issue of ALR booking delays, providing users with a huge selection of instantly bookable ALR property choices throughout the world — instant confirmation, no waiting! NextTrip also lets users book other major travel services while they’re shopping for ALR properties, including conventional hotels, airlines, car rentals and tour packages, making NextTrip a true one-stop shop for travelers everywhere. In all, the NextTrip website and mobile app list over 1.2 million instantly bookable ALR properties along with 200,000 hotels, 400 airlines, every major rental car company and 10,000 activities for tourists.
The Monaker Booking Engine (MBE), a new cloud-based technology platform, powers NextTrip, delivering Monaker’s worldwide ALR inventory through a flexible API that also supports the distribution of the company’s ALR products to B2B travel industry partners. The company’s MBE and API have been built to the very latest industry standards, enabling customer integration into virtually any existing travel booking system.
ALR is one of the fastest growing sectors in the travel industry and is projected to grow at more than seven percent CAGR to reach $194 billion by 2021. The global online travel market is expected to reach $1,091 billion by 2022, according to a recent report from Allied Market Research. Monaker is seeking to capitalize on these incredible growth projections as it meets the rapidly increasing demand for easily bookable alternative lodging.
For more information, visit www.MonakerGroup.com or www.NextTrip.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, June 14, 2017
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is “One to Watch”
With more than a century of combined experience spanning the gamut from pancreas/GI tract issues in hepato-gastroenterology and infectious disease to the development of novel non-systemic (localized) therapeutic biologics and proteomics (protein engineering), the AzurRx BioPharma, Inc. (NASDAQ: AZRX) core science team is the real strength behind the company’s developing portfolio of recombinant therapies. AzurRx has come quite a long way on the strength of its science-driven approach and today stands tall upon the IP foundation of its two main pipeline programs. The lead candidate of which, MS1819 lipase, is currently in ongoing, open-label Phase IIa trials in EPI (exocrine pancreatic insufficiency) associated with chronic pancreatitis (CP). Human trialing where this novel, orally delivered, non-systemic (non-absorbable, locally-acting, does not reach systemic circulation), yeast-derived recombinant enzyme has already shown solid dose responses at various levels with no apparent safety issues.
Given such positive Phase IIa in vivo study data (reported in mid-April 2017), where the efficacy of MS1819 is characterized by a 20 percent increase in the coefficient of fat absorption in all patients (or CFA, the primary efficacy endpoint), AZRX is confident that its lead candidate will continue to show a marked superiority to currently marketed, porcine-derived pancreatic enzyme replacement therapies (PERTs). With an anticipated completion of the MS1819 Phase IIa in the third-quarter of 2017 and strong applications for the drug in EPI associated with CF (cystic fibrosis), as well as demonstrably apparent efficacy in CP-associated EPI, the $8.50 valuation set by Zacks Small-Cap Research earlier this year (January, April) looks well within striking distance (given that the projection is based on a 2020 launch of MS1819).
A recent report from April of 2017 by GlobalData paints a bullish picture for the broader CF market with a CAGR of around 13.6 percent through 2025 when it will reach upwards of $7.6 billion on the strength of new drugs becoming available. This is exciting news when contrasted with the Transparency Market Research projection from last year, which depicts the EPI space alone to be worth around $2.85 billion by 2023, on a CAGR of some 8.3 percent, with the U.S. representing roughly 57 percent of that global pie. The PERT market is currently dominated by a small handful of players, with the AbbVie (NYSE: ABBV) drug Creon accounting for the lion’s share, and newer, more technologically advanced entrants such as Allergan’s (NYSE: AGN) Ultresa currently being seen by analysts as having the highest future growth rate.
However, these drugs and other PERTs such as Nutrizym, Pancrease and Pancrex are derived from pig pancreas gland extracts, carry a pork viral contamination risk, and thus represent a biopharma niche that is ripe for disruption by an innovator like AZRX.
PERT Demand May be Larger than Expected
Somewhere from 10 to 12 million people in the U.S. are estimated to carry the defective CF gene that leads to CF, and while the patient population is only around 30,000 or more, it can be inferred from CDC statistics that there are approximately 400 or more new cases in the U.S. alone each year (around 1,000 worldwide). CF is also no longer considered a childhood disease like it was only a few decades ago, because patients are now able to more effectively manage the disease via therapy and have an average life expectancy of around 37 years. EPI is observed to occur in 85 to 90 percent of CF patients according to research done by one of the most trusted names in pathology, Robbins Basic Pathology.
With the rate of CP around 50/100,000, and a growing awareness of the influence of diabetes on pancreatic exocrine function, the emergence of a yeast-derived recombinant enzyme therapy such as MS1819 is really something to take note of, especially due to the fact that AZRX’s offering has shown high potency in low pH environments (stable in protease and bile salt environments), and activity in long chain fats. EPI affects as many as half of all the people with insulin-dependent diabetes by some estimates, and it is well-known that CP patients typically develop type 3c diabetes. The key takeaway in all of this is that there is a growing market for MS1819, a drug which is now clearly underscoring the success of earlier Phase Ib in vitro work, during in its ongoing Phase IIa in vivo trial.
Phase IIb Enabling Trial & Successful Placement Very Bullish
CEO of AzurRx BioPharma, Thijs Spoor, was clearly pleased by extant Phase IIa results with MS1819, pointing to the observably robust dose-response pattern and overall safety characteristics. Anticipation is high that MS1819 will prove to be a more effective and safer alternative to existing PERTs. Given the warm reception by patients, as well as physicians noted by the Clinical Investigator, this drug could gobble up market share very quickly.
It’s little wonder then that the recent private placement financing (closing announced June 8) went so well, with the issuance designed to fund the MS1819 program being over-subscribed, allowing AZRX to rake in gross proceeds of some $5 million. The $3.50 priced units in the placement consisted of a share of common stock, one Series A Warrant for 0.25 shares at $4.00 (exercisable through Dec 31, 2017), and one Series A-1 Warrant for 0.75 shares at $5.50 (exercisable six months after closing through June 6, 2022).
Potential Sleeper Hit in the Wings
The second program under development by AZRX at this time is another oral non-systemic, AZX1101 (recombinant beta-lactamase derived from a bacterial source), which is in the preclinical stage for localized shielding of the GI tract against HAIs (hospital-acquired infections) associated with broad-spectrum beta-lactam antibiotic use. Beta-lactam antibiotics (especially penicillins and cephalosporins) have really come into their own as the drugs of choice for many infections, but their use is also frighteningly threatened by the emergence of increasingly resistant strains of bacteria.
This could be a nice one-two punch lineup for AZRX, with MS1819 commercialization supercharging the development ramp for AZX1101, amid a global infection control market that is on-track to run a 6.5 percent CAGR through 2021, reaching around $17.78 billion on the dominance of factors such as the growing prevalence of HAIs. It is worth noting that the Zacks Small-Cap Research doesn’t even factor the potential upside from AZX1101 into its $8.50 price target, despite the admittedly substantial market opportunity.
To take a closer look, visit http://www.azurrx.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Given such positive Phase IIa in vivo study data (reported in mid-April 2017), where the efficacy of MS1819 is characterized by a 20 percent increase in the coefficient of fat absorption in all patients (or CFA, the primary efficacy endpoint), AZRX is confident that its lead candidate will continue to show a marked superiority to currently marketed, porcine-derived pancreatic enzyme replacement therapies (PERTs). With an anticipated completion of the MS1819 Phase IIa in the third-quarter of 2017 and strong applications for the drug in EPI associated with CF (cystic fibrosis), as well as demonstrably apparent efficacy in CP-associated EPI, the $8.50 valuation set by Zacks Small-Cap Research earlier this year (January, April) looks well within striking distance (given that the projection is based on a 2020 launch of MS1819).
A recent report from April of 2017 by GlobalData paints a bullish picture for the broader CF market with a CAGR of around 13.6 percent through 2025 when it will reach upwards of $7.6 billion on the strength of new drugs becoming available. This is exciting news when contrasted with the Transparency Market Research projection from last year, which depicts the EPI space alone to be worth around $2.85 billion by 2023, on a CAGR of some 8.3 percent, with the U.S. representing roughly 57 percent of that global pie. The PERT market is currently dominated by a small handful of players, with the AbbVie (NYSE: ABBV) drug Creon accounting for the lion’s share, and newer, more technologically advanced entrants such as Allergan’s (NYSE: AGN) Ultresa currently being seen by analysts as having the highest future growth rate.
However, these drugs and other PERTs such as Nutrizym, Pancrease and Pancrex are derived from pig pancreas gland extracts, carry a pork viral contamination risk, and thus represent a biopharma niche that is ripe for disruption by an innovator like AZRX.
PERT Demand May be Larger than Expected
Somewhere from 10 to 12 million people in the U.S. are estimated to carry the defective CF gene that leads to CF, and while the patient population is only around 30,000 or more, it can be inferred from CDC statistics that there are approximately 400 or more new cases in the U.S. alone each year (around 1,000 worldwide). CF is also no longer considered a childhood disease like it was only a few decades ago, because patients are now able to more effectively manage the disease via therapy and have an average life expectancy of around 37 years. EPI is observed to occur in 85 to 90 percent of CF patients according to research done by one of the most trusted names in pathology, Robbins Basic Pathology.
With the rate of CP around 50/100,000, and a growing awareness of the influence of diabetes on pancreatic exocrine function, the emergence of a yeast-derived recombinant enzyme therapy such as MS1819 is really something to take note of, especially due to the fact that AZRX’s offering has shown high potency in low pH environments (stable in protease and bile salt environments), and activity in long chain fats. EPI affects as many as half of all the people with insulin-dependent diabetes by some estimates, and it is well-known that CP patients typically develop type 3c diabetes. The key takeaway in all of this is that there is a growing market for MS1819, a drug which is now clearly underscoring the success of earlier Phase Ib in vitro work, during in its ongoing Phase IIa in vivo trial.
Phase IIb Enabling Trial & Successful Placement Very Bullish
CEO of AzurRx BioPharma, Thijs Spoor, was clearly pleased by extant Phase IIa results with MS1819, pointing to the observably robust dose-response pattern and overall safety characteristics. Anticipation is high that MS1819 will prove to be a more effective and safer alternative to existing PERTs. Given the warm reception by patients, as well as physicians noted by the Clinical Investigator, this drug could gobble up market share very quickly.
It’s little wonder then that the recent private placement financing (closing announced June 8) went so well, with the issuance designed to fund the MS1819 program being over-subscribed, allowing AZRX to rake in gross proceeds of some $5 million. The $3.50 priced units in the placement consisted of a share of common stock, one Series A Warrant for 0.25 shares at $4.00 (exercisable through Dec 31, 2017), and one Series A-1 Warrant for 0.75 shares at $5.50 (exercisable six months after closing through June 6, 2022).
Potential Sleeper Hit in the Wings
The second program under development by AZRX at this time is another oral non-systemic, AZX1101 (recombinant beta-lactamase derived from a bacterial source), which is in the preclinical stage for localized shielding of the GI tract against HAIs (hospital-acquired infections) associated with broad-spectrum beta-lactam antibiotic use. Beta-lactam antibiotics (especially penicillins and cephalosporins) have really come into their own as the drugs of choice for many infections, but their use is also frighteningly threatened by the emergence of increasingly resistant strains of bacteria.
This could be a nice one-two punch lineup for AZRX, with MS1819 commercialization supercharging the development ramp for AZX1101, amid a global infection control market that is on-track to run a 6.5 percent CAGR through 2021, reaching around $17.78 billion on the dominance of factors such as the growing prevalence of HAIs. It is worth noting that the Zacks Small-Cap Research doesn’t even factor the potential upside from AZX1101 into its $8.50 price target, despite the admittedly substantial market opportunity.
To take a closer look, visit http://www.azurrx.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX’s goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role in the future of legalized cannabis, with Prime Minister Justin Trudeau having previously introduced legislation to legalize the recreational use of marijuana by the middle of 2018. When these measures are completed, Canada is expected to become just the second country to completely legalize marijuana as a consumer product.
To view the full press release, visit http://dtn.fm/z0AfM
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/z0AfM
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Tuesday, June 13, 2017
ChineseInvestors.com, Inc. (CIIX) Participates In SeeThruEquity Microcap Investor Conference, Receives Research Report Confidence in its Cannabis Market Penetration and Growth
ChineseInvestors.com, Inc. (OTCQB: CIIX) participated in SeeThruEquity’s 6th Annual Microcap Investor Conference on June 1, 2017, in New York. That conference gives investors the exclusive opportunity to discover publicly traded companies with market capitalization of less than $1 billion.
CIIX offers educational consulting services for Chinese investors. Most recently, it has been pursuing opportunities in the cannabis market. The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in San Gabriel, California. There, it will sell primarily hemp oil-based products. The company is based in San Gabriel, California.
“SeeThruEquity gave CIIX a price target of $2.05 one year ago,” Warren Wang, founder and CEO of CIIX, noted in a news release. “Recently, the firm increased CIIX’s price target to $3.75, reflecting huge growth potential based on our legal medical cannabis initiatives. In addition, SeeThruEquity also gave CIIX a forecast for revenue from its hemp business projecting the revenue could grow from $0.7 million in FY2017 to reach 8-digit sales by FY2020E, with continued growth thereafter.”
SeeThruEquity (http://dtn.fm/HC0yY) increased the price target on CIIX based on the potential for the company’s legal cannabis initiatives. These include CIIX’s early stage efforts to penetrate the market and the research company’s belief that CIIX can capitalize on its approach to broad cannabis industry growth.
“We view CIIX as a high-risk/high-reward investment opportunity in the microcap space, with potential of upside if the company can generate renewed traction with its high margin investor relations services business and execute on the new cannabis initiatives,” the report said.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
CIIX offers educational consulting services for Chinese investors. Most recently, it has been pursuing opportunities in the cannabis market. The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in San Gabriel, California. There, it will sell primarily hemp oil-based products. The company is based in San Gabriel, California.
“SeeThruEquity gave CIIX a price target of $2.05 one year ago,” Warren Wang, founder and CEO of CIIX, noted in a news release. “Recently, the firm increased CIIX’s price target to $3.75, reflecting huge growth potential based on our legal medical cannabis initiatives. In addition, SeeThruEquity also gave CIIX a forecast for revenue from its hemp business projecting the revenue could grow from $0.7 million in FY2017 to reach 8-digit sales by FY2020E, with continued growth thereafter.”
SeeThruEquity (http://dtn.fm/HC0yY) increased the price target on CIIX based on the potential for the company’s legal cannabis initiatives. These include CIIX’s early stage efforts to penetrate the market and the research company’s belief that CIIX can capitalize on its approach to broad cannabis industry growth.
“We view CIIX as a high-risk/high-reward investment opportunity in the microcap space, with potential of upside if the company can generate renewed traction with its high margin investor relations services business and execute on the new cannabis initiatives,” the report said.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Reports Confirmed PATSCAN CMR™ Sales Commitments of $2.7M
Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF), developer of the award-winning PATSCAN CMR™ concealed weapons detection system, this morning announced that it has recorded $2.7 million in confirmed sales commitment since commencing product marketing just three months ago ahead of the ISC West trade show in Las Vegas. “Our roll-out program initially conceived finalizing our engineering in early spring in order to meet Industry Canada and FCC certification requirements by late summer,” Dinesh Kandanchatha, president and CTO of Patriot One, stated in the news release. “We have informed our supply chain partners of the accelerating demand, and I am confident that our scalable manufacturing processes will be well equipped to fulfil our orders.” To date, Patriot One’s sales efforts have focused primarily on locations at high risk of terrorist attack, including houses of worship, academic institutions, event centers, casinos, commercial offices, hotel properties and government agencies. In line with these efforts, the company has received orders from locations spanning four continents. Patriot One is currently exploring the use of special waivers that could allow for the immediate deployment of its PATSCAN CMR™ system to users demonstrating need under certification exemption guidelines.
To view the full press release, visit http://dtn.fm/6WimU
About Patriot One Technologies, Inc.
Patriot One has developed PATSCAN CMR™ the next generation of its award-winning Patriot One Technologies™ NForce CMR1000 software and radar solution. PATSCAN CMR is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system as an effective tool to combat active shooter threats before they occur. Designed for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The Company’s motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit: www.patriot1tech.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/6WimU
About Patriot One Technologies, Inc.
Patriot One has developed PATSCAN CMR™ the next generation of its award-winning Patriot One Technologies™ NForce CMR1000 software and radar solution. PATSCAN CMR is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system as an effective tool to combat active shooter threats before they occur. Designed for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The Company’s motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit: www.patriot1tech.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Monday, June 12, 2017
Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is “One to Watch”
Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.
Developed through a NATO-funded project at McMaster University, Patriot One’s disruptive NForce CMR1000 (PATSCAN) technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.
A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world’s population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren’t taken.
Patriot One’s patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a “cognitive” ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.
In contrast, Patriot One’s technology is small in size and can be “covertly” placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.
The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.
The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.
Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols.
For more information, visit the company’s website at www.Patriot1Tech.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Developed through a NATO-funded project at McMaster University, Patriot One’s disruptive NForce CMR1000 (PATSCAN) technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.
A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world’s population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren’t taken.
Patriot One’s patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a “cognitive” ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.
In contrast, Patriot One’s technology is small in size and can be “covertly” placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.
The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.
The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.
Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols.
For more information, visit the company’s website at www.Patriot1Tech.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the exclusive licensee of the U.S. patent filing entitled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’. If the patent filing is granted and proven, IGC anticipates that it could create a “significant therapeutic pathway” in the Alzheimer’s disease market, which is expected to record direct costs in excess of $450 billion annually in the next 12 years. “Securing this licensing agreement from the University of South Florida represents a major turning point for IGC as we now look to prepare several of our key products for clinical trials,” Ram Mukunda, CEO of IGC, stated in the news release. “We have worked hard to assemble a strong development team and a primary pipeline of four major products addressing large markets and possible blockbuster indications utilizing cannabis-based therapies. We are putting the finishing touches on our products, which may include filing additional patents, and we very much expect to start pursuing clinical trials for our Alzheimer’s product and others this year.”
To view the full press release, visit http://dtn.fm/Zwr6R
About IGC
India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/Zwr6R
About IGC
India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information visit www.igcinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Friday, June 9, 2017
MissionIRNewsBreaks – Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Steps Up Exploration Efforts in Wake of Chinese Production Cuts
As China recently increased its import of zinc in the wake of production halts – part of an environmental crackdown on China’s steel industry – global zinc prices subsequently soared. With worldwide zinc inventories already under pressure due to increasing demand, China’s efforts to curb zinc and nickel production will likely continue significantly impacting the global supply, and zinc exploration corporations like Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) are hastening to step up their efforts to find deposits and help slake this global shortage.
“China’s move is likely to drive zinc demand even higher. According to the International Lead and Zinc Study Group, demand for the metal is already exceeding supply, and the difference is expected to reach 226,000 tons this year (http://dtn.fm/Igk5t). To help meet the rising demand, Canada’s Kootenay Zinc Corp. has already taken steps to expand its exploration program at its Sully property in British Columbia. The property is located near the legendary Sullivan Mine, which was one of the world’s largest reserves of zinc, with an output of over 17 million tons of zinc and lead until it was closed down in 2001. Kootenay’s Sully Project is located 18 miles from Sullivan, and both properties share different environments of the same basin.”
To view the full article, visit http://dtn.fm/Xsc3p
About Kootenay Zinc Corp.
Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The Company is focused on discovering large-scale sedimentary-exhalative (“SEDEX”) deposits. The Sully Property comprises 1,375 hectares located approximately 30 kilometres (18 miles) east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property. For more information visit www.kootenayzinc.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
“China’s move is likely to drive zinc demand even higher. According to the International Lead and Zinc Study Group, demand for the metal is already exceeding supply, and the difference is expected to reach 226,000 tons this year (http://dtn.fm/Igk5t). To help meet the rising demand, Canada’s Kootenay Zinc Corp. has already taken steps to expand its exploration program at its Sully property in British Columbia. The property is located near the legendary Sullivan Mine, which was one of the world’s largest reserves of zinc, with an output of over 17 million tons of zinc and lead until it was closed down in 2001. Kootenay’s Sully Project is located 18 miles from Sullivan, and both properties share different environments of the same basin.”
To view the full article, visit http://dtn.fm/Xsc3p
About Kootenay Zinc Corp.
Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The Company is focused on discovering large-scale sedimentary-exhalative (“SEDEX”) deposits. The Sully Property comprises 1,375 hectares located approximately 30 kilometres (18 miles) east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property. For more information visit www.kootenayzinc.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Thursday, June 8, 2017
MissionIRNewsBreaks – Grey Cloak Tech (GRCK) Enables Integration of Brick-and-Mortar and E-Commerce Omni-Channel Shopping
Now a dual-faceted company following its March 2017 takeover of ShareRails and its cloud-based software, Grey Cloak Tech (OTC: GRCK) is poised to play a significant role as major retailers seek to successfully integrate their physical stores with e-commerce to keep stride with the changing retail market. The proprietary software offered through ShareRails presents a promising solution in the battle of brick-and-mortar stores versus online companies, enabling storefront merchants to compete in the omni-channel shopping world and drive business to their physical locations through the use of e-commerce tools.
“ShareRails’ proprietary software could be a key element in the survival and growth of stores, located in malls, strip centers, or freestanding, versus online companies that are nimble in pricing and assortments. Grey Cloak Tech, after its March 2017 takeover of ShareRails, is now a dual-faceted company. It can use its newly-acquired online-to-offline (O2O) platform to raise the profile of retailers’ inventory in brick-and-mortar stores into online digital comparison shopping. Through a digital conversion of a listing of physical inventory into rich content, a number of search engines — such as Google — can then index the products offered. The endgame is a melding of online shopping with physical stores.”
To view the full article, visit http://dtn.fm/R1nxm
About Grey Cloak Tech and ShareRails
ShareRails Online to Offline Platform (O2O) levels the digital playing field between e-commerce stores and brick-and-mortar stores by transforming local retailers’ inventory data into rich digital content that is then indexed by Google and other search engines. ShareRails’ platform, once set up attracts prospective customers via online channels to physical stores where they can pick their item up. This serves the “instant gratification” mentality of today’s consumer. Using Internet marketing, social media and email marketing, ShareRails makes it easy for brick and mortar stores to become visible to millions more online shoppers. In addition to the O2O e-commerce services by ShareRails, Grey Cloak offers industry-leading click-fraud detection software. Click fraud, or bot fraud, cost unsuspecting advertisers approximately $18.5 billion annually in 2015. For more information on Grey Cloak, visit www.greycloaktech.com. For more information on ShareRails, visit www.ShareRails.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
“ShareRails’ proprietary software could be a key element in the survival and growth of stores, located in malls, strip centers, or freestanding, versus online companies that are nimble in pricing and assortments. Grey Cloak Tech, after its March 2017 takeover of ShareRails, is now a dual-faceted company. It can use its newly-acquired online-to-offline (O2O) platform to raise the profile of retailers’ inventory in brick-and-mortar stores into online digital comparison shopping. Through a digital conversion of a listing of physical inventory into rich content, a number of search engines — such as Google — can then index the products offered. The endgame is a melding of online shopping with physical stores.”
To view the full article, visit http://dtn.fm/R1nxm
About Grey Cloak Tech and ShareRails
ShareRails Online to Offline Platform (O2O) levels the digital playing field between e-commerce stores and brick-and-mortar stores by transforming local retailers’ inventory data into rich digital content that is then indexed by Google and other search engines. ShareRails’ platform, once set up attracts prospective customers via online channels to physical stores where they can pick their item up. This serves the “instant gratification” mentality of today’s consumer. Using Internet marketing, social media and email marketing, ShareRails makes it easy for brick and mortar stores to become visible to millions more online shoppers. In addition to the O2O e-commerce services by ShareRails, Grey Cloak offers industry-leading click-fraud detection software. Click fraud, or bot fraud, cost unsuspecting advertisers approximately $18.5 billion annually in 2015. For more information on Grey Cloak, visit www.greycloaktech.com. For more information on ShareRails, visit www.ShareRails.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Wednesday, June 7, 2017
Kootenay Zinc Corporation (CSE: ZNK) (OTCQB: KTNNF) Has Star Prospectors on the Job at the Sully Project
In the modern world, zinc plays second fiddle to iron. About half of the blue-white or blue-gray metal mined is used in coating iron to prevent the latter from rusting, a process known as galvanization. However, it is clear from archaeological discoveries that zinc had a much more important role in earlier times. For example, brass artifacts dated before 1000 BCE have been found in Palestine. Brass is a metal alloy composed of copper and zinc. Given zinc’s venerable past, the Kootenay Zinc Corporation (CSE: ZNK) (OTCQB: KTNNF) is betting the lustrous mineral will continue to have an important role in the future. A sextet of star prospectors is guiding the British Columbia-based junior exploration and mining company as it continues its quest for the metal with atomic number 30.
Supplies of zinc have been contracting since late 2015, when a number of major mines were closed or were winding down operations. In April 2015, Vedanta Resources announced that it would close its Lisheen Mine in Ireland. The last shipment from the mine in Tipperary County took place in January 2016, according to this report (http://dtn.fm/cX1bz) in the Irish Times. Lisheen was Europe’s second largest zinc mine with a capacity of around 175,000 tons. Then, in October 2015, Australian-Chinese concern MMG Limited (HKG: 1208) announced (http://dtn.fm/Y4Pf3) that, after 16 years, mining at Century, Australia’s largest open-pit zinc mine, had “completed” in August 2015. At one time the world’s third largest zinc mine, Century was still producing around 465,696 tons, or 3.5% of global zinc output, in its last full year. Also in October 2015, the Anglo-Swiss mining giant Glencore said it would cut zinc production across its mines worldwide by 500,000 tons, about one-third of its annual output, according to CNBC (http://dtn.fm/R1ThX).
That wasn’t the end of it. Zinc mines in China were also shuttered. A 2016 report (http://dtn.fm/tmE0J) disclosed that Beijing has ordered the shutdown of a number of zinc mines in Hunan Province, the center of Chinese production, owing to safety and environmental concerns. However, at the same time as these supply constraints multiplied, demand was set to increase, since China’s gargantuan infrastructural One Belt, One Road initiative was gathering pace. Formally announced by President Xi Jinping in 2013, the global project is expected to increase demand for steel and, consequently, zinc. As a result, analysts at Goldman Sachs wrote in a research note recently that “Zinc Has by Far The Most Bullish Supply Side Dynamic”, according to several reports.
As Kootenay continues its search for zinc at the Sully property, a 1,375 hectare concession located near Kimberley, B.C., it has enlisted the talent of six star prospectors. Making up that illustrious sextet are Peter Meredith, Jonathan Rubenstein, Stuart (Tookie) Angus, Paul Ransom, David Broughton and Brian Jones.
Peter Meredith sits on the advisory board. He is a current director of Ivanhoe Mines Ltd. and a former deputy chairman and CFO. The chairman of Mag Silver Corp., Jonathan Rubenstein is also on the advisory board, as is Tookie Angus, the current chairman of zinc producer Nevsun Resources Ltd., which operates one of the highest-grade open-pit copper mines in the world.
The technical team includes Paul Ransom, a geologist and noted Sullivan SEDEX deposit expert. He worked for 33 years at the Sullivan Mine and Cominco (now Teck Resources). Ransom has also authored and/or co-authored 10 papers on the geology of the Sullivan deposit. He is Sully Project Manager. Dr. David Broughton, senior technical advisor, is also on the technical team. He is a recognized expert in sediment-hosted copper deposits and spearheaded the discovery of two major mineral deposits, Kamoa in the Democratic Republic of Congo (DRC) and the Platreef in South Africa for Ivanhoe Mines. The technical team also includes Brian Jones (Excel Geophysics), a noted gravity expert involved in high profile, large-scale surveys for mineral exploration and resource estimates, including the Voisey’s Bay Project.
The Sully property is hosted in rocks of similar age and origin as those of the legendary Sullivan deposit. Located only 18 miles (30 kilometers) east of Kimberley and the Sullivan Mine, Kootenay’s star team could strike zinc any day.
For more information, visit the company’s website at www.KootenayZinc.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Supplies of zinc have been contracting since late 2015, when a number of major mines were closed or were winding down operations. In April 2015, Vedanta Resources announced that it would close its Lisheen Mine in Ireland. The last shipment from the mine in Tipperary County took place in January 2016, according to this report (http://dtn.fm/cX1bz) in the Irish Times. Lisheen was Europe’s second largest zinc mine with a capacity of around 175,000 tons. Then, in October 2015, Australian-Chinese concern MMG Limited (HKG: 1208) announced (http://dtn.fm/Y4Pf3) that, after 16 years, mining at Century, Australia’s largest open-pit zinc mine, had “completed” in August 2015. At one time the world’s third largest zinc mine, Century was still producing around 465,696 tons, or 3.5% of global zinc output, in its last full year. Also in October 2015, the Anglo-Swiss mining giant Glencore said it would cut zinc production across its mines worldwide by 500,000 tons, about one-third of its annual output, according to CNBC (http://dtn.fm/R1ThX).
That wasn’t the end of it. Zinc mines in China were also shuttered. A 2016 report (http://dtn.fm/tmE0J) disclosed that Beijing has ordered the shutdown of a number of zinc mines in Hunan Province, the center of Chinese production, owing to safety and environmental concerns. However, at the same time as these supply constraints multiplied, demand was set to increase, since China’s gargantuan infrastructural One Belt, One Road initiative was gathering pace. Formally announced by President Xi Jinping in 2013, the global project is expected to increase demand for steel and, consequently, zinc. As a result, analysts at Goldman Sachs wrote in a research note recently that “Zinc Has by Far The Most Bullish Supply Side Dynamic”, according to several reports.
As Kootenay continues its search for zinc at the Sully property, a 1,375 hectare concession located near Kimberley, B.C., it has enlisted the talent of six star prospectors. Making up that illustrious sextet are Peter Meredith, Jonathan Rubenstein, Stuart (Tookie) Angus, Paul Ransom, David Broughton and Brian Jones.
Peter Meredith sits on the advisory board. He is a current director of Ivanhoe Mines Ltd. and a former deputy chairman and CFO. The chairman of Mag Silver Corp., Jonathan Rubenstein is also on the advisory board, as is Tookie Angus, the current chairman of zinc producer Nevsun Resources Ltd., which operates one of the highest-grade open-pit copper mines in the world.
The technical team includes Paul Ransom, a geologist and noted Sullivan SEDEX deposit expert. He worked for 33 years at the Sullivan Mine and Cominco (now Teck Resources). Ransom has also authored and/or co-authored 10 papers on the geology of the Sullivan deposit. He is Sully Project Manager. Dr. David Broughton, senior technical advisor, is also on the technical team. He is a recognized expert in sediment-hosted copper deposits and spearheaded the discovery of two major mineral deposits, Kamoa in the Democratic Republic of Congo (DRC) and the Platreef in South Africa for Ivanhoe Mines. The technical team also includes Brian Jones (Excel Geophysics), a noted gravity expert involved in high profile, large-scale surveys for mineral exploration and resource estimates, including the Voisey’s Bay Project.
The Sully property is hosted in rocks of similar age and origin as those of the legendary Sullivan deposit. Located only 18 miles (30 kilometers) east of Kimberley and the Sullivan Mine, Kootenay’s star team could strike zinc any day.
For more information, visit the company’s website at www.KootenayZinc.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Pursues Clinical Trials of Cannabis-Based Combination Therapies with Assistance of New Advisor
India Globalization Capital (NYSE MKT: IGC) recently named Craig Cheifetz, M.D. as an advisor to assist the company with its clinical trials in microbiology, immunology, neuroscience and biotechnology. IGC CEO Ram Mukunda stated in a news release that the company looks forward to Dr. Cheifetz’s contributions as IGC moves forward in the development of unique cannabis combination therapies. “The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for indications including depression, Alzheimer’s and Parkinson’s disease. Its lead candidate is IGC-501, and it has filed patents for the candidate in the United States, Canada and Europe.”
To view the full article, visit http://dtn.fm/Yn07f
About India Globalization Capital, Inc.
India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full article, visit http://dtn.fm/Yn07f
About India Globalization Capital, Inc.
India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Tuesday, June 6, 2017
India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy
With about 50 million people affected worldwide, drug-resistant epilepsy, or refractory epilepsy, is a very serious condition for which a medical solution has not yet been found, but the therapeutic benefits of phytocannabinoid-based therapies for seizures have been coming under increased scrutiny lately. There is mounting evidence that cannabinoid extracts, and in particular cannabidiol (CBD), can have a positive impact on epilepsy patients and alleviate seizures, as indicated by recent research. Companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are at the forefront of discovering cannabinoid-based epilepsy treatments for humans and animals alike, by developing innovative formulations that can change the paradigm of seizure therapies.
Although stories of cannabis benefits for seizure patients have been around for more than a century, the interest in marijuana has increased significantly in the last few years due to the growing legalization movement. At the moment, marijuana is legal for medical or recreational consumption in almost 30 states, and supporters of legalization hope the substance will eventually be allowed nationwide. There is also hope that widespread legalization will eventually force the federal government to declassify marijuana as a Schedule I drug, a classification that currently stands in the way of the cannabis industry’s potential development mostly by limiting businesses’ access to banking and financial solutions.
Most research into the effects of cannabis on epilepsy has focused on CBD, the most abundant non-psychoactive cannabinoid in the marijuana plant. According to the American Epilepsy Society (http://dtn.fm/6bMxP), recent studies have indicated that CBD was successfully used to reduce the intensity and frequency of seizures in children with refractory epilepsy. Multiple other studies have indicated similar results, in particular a dramatic drop in the number of seizures reported by patients who were given CBD-based treatments, according to the Epilepsy Foundation (http://dtn.fm/cxG3P). The same effects were reported for CBD use to treat veterinary epilepsy in multiple species, most notably in cats and dogs. The second most abundant cannabinoid extract, tetrahydrocannabinol (THC), was also found to have a positive impact on epilepsy patients, but it is not as easily tolerated due to its psychotropic properties.
Maryland-based IGC is developing innovative CBD-based therapies targeting both human and veterinary epilepsy, as well as other types of seizures. The company has already filed for a U.S. patent for the formulation, administered via different delivery technologies, and has plans to start metabolic profiling and apply to the Food and Drug Administration to start clinical trials. One of its product candidates targeting seizures in animals, IGC-502, is scheduled to begin clinical trials this year.
In addition to seizures, IGC has developed a pipeline of cannabinoid-based therapies targeting various major disorders, including eating disorders and neuropathic pain. The company is becoming a leader in the use of combination therapies that pair cannabis extracts with other traditional medications for the treatment of different conditions, positioning itself as a unique and interesting investment option on the ever-growing medical marijuana market.
For more information, visit the company’s website at www.IGCinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Although stories of cannabis benefits for seizure patients have been around for more than a century, the interest in marijuana has increased significantly in the last few years due to the growing legalization movement. At the moment, marijuana is legal for medical or recreational consumption in almost 30 states, and supporters of legalization hope the substance will eventually be allowed nationwide. There is also hope that widespread legalization will eventually force the federal government to declassify marijuana as a Schedule I drug, a classification that currently stands in the way of the cannabis industry’s potential development mostly by limiting businesses’ access to banking and financial solutions.
Most research into the effects of cannabis on epilepsy has focused on CBD, the most abundant non-psychoactive cannabinoid in the marijuana plant. According to the American Epilepsy Society (http://dtn.fm/6bMxP), recent studies have indicated that CBD was successfully used to reduce the intensity and frequency of seizures in children with refractory epilepsy. Multiple other studies have indicated similar results, in particular a dramatic drop in the number of seizures reported by patients who were given CBD-based treatments, according to the Epilepsy Foundation (http://dtn.fm/cxG3P). The same effects were reported for CBD use to treat veterinary epilepsy in multiple species, most notably in cats and dogs. The second most abundant cannabinoid extract, tetrahydrocannabinol (THC), was also found to have a positive impact on epilepsy patients, but it is not as easily tolerated due to its psychotropic properties.
Maryland-based IGC is developing innovative CBD-based therapies targeting both human and veterinary epilepsy, as well as other types of seizures. The company has already filed for a U.S. patent for the formulation, administered via different delivery technologies, and has plans to start metabolic profiling and apply to the Food and Drug Administration to start clinical trials. One of its product candidates targeting seizures in animals, IGC-502, is scheduled to begin clinical trials this year.
In addition to seizures, IGC has developed a pipeline of cannabinoid-based therapies targeting various major disorders, including eating disorders and neuropathic pain. The company is becoming a leader in the use of combination therapies that pair cannabis extracts with other traditional medications for the treatment of different conditions, positioning itself as a unique and interesting investment option on the ever-growing medical marijuana market.
For more information, visit the company’s website at www.IGCinc.us
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Targeting the Next Legendary Mine
The production, longevity, and riches are legendary; 337 million ounces of silver and more than 17 million tons of lead and zinc were produced during nearly a century of operation. Today’s value of the minerals taken is nearly $50 billion dollars. Put in perspective, the nine million tons of lead produced during its lifetime by the astonishing Sullivan Mine in British Columbia was enough lead to manufacture 500 million lead-acid batteries for automobiles, and the mine also produced enough zinc, eight million tons, to supply the zinc content in 160 million cars.
In addition to a treasure trove of minerals, the Sullivan Mine provided immense ancillary benefits to mine employees and surrounding communities. It’s estimated that Sullivan paid in excess of $5 billion in wages and benefits and another $20 billion in direct contribution to the local economies, such as taxes, payments to suppliers and the purchase of local services. Economists postulate that Sullivan’s $20 billion in direct contributions equated to three times that amount in indirect effects (local retail, services, housing, education, etc.), or another $60 billion added to the economy. These are unquestionably impressive contributions from the Sullivan Mine, which remains the largest SEDEX deposit uncovered to date.
SEDEX, or sedimentary exhalative deposits, are ore deposits formed when hydrothermal fluids enter a water reservoir, such as an ocean, and discharge minerals. Geology validates the value of SEDEX deposits, which have proven to be a major source of high grade minerals including copper, silver, gold and tungsten, as well as being the world’s single most important source of both lead and zinc.
The value of high grade SEDEX deposits is further crystallized by looking at the increasing value of the underlying minerals. The intrinsic nature of silver and gold are overshadowed by the current shortage and increased global demand for zinc. Zinc prices have exploded over 60 percent this year, to $1.17 per pound in May 2017 from $0.70 per pound one year ago, and zinc appears to be poised to break even higher due to a projected shortage of about 500,000 tons this year. Zinc is indispensable in building materials, automotive, galvanized steel and the production of batteries.
With the famed Sullivan Mine shut down, attention has now turned to what may become the planet’s next legendary SEDEX deposit. In line with these efforts, Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is ramping up exploration of its Sully Project. Located just 18 miles from Sullivan, the same sedimentary rocks that host Sullivan are present at Sully and could be different environments of the same basin. Paul Ransom, respected geologist and noted Sullivan SEDEX deposit expert, has called the Sully Project, “…the best exploration target of Sullivan Size that I have seen in my (33 year) career.”
So far, drilling efforts at the Sully Project have been deemed a very near miss, and Kootenay Zinc has undertaken the necessary steps to target what may well become the world’s next great SEDEX deposit.
For more information, visit the company’s website at www.KootenayZinc.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
In addition to a treasure trove of minerals, the Sullivan Mine provided immense ancillary benefits to mine employees and surrounding communities. It’s estimated that Sullivan paid in excess of $5 billion in wages and benefits and another $20 billion in direct contribution to the local economies, such as taxes, payments to suppliers and the purchase of local services. Economists postulate that Sullivan’s $20 billion in direct contributions equated to three times that amount in indirect effects (local retail, services, housing, education, etc.), or another $60 billion added to the economy. These are unquestionably impressive contributions from the Sullivan Mine, which remains the largest SEDEX deposit uncovered to date.
SEDEX, or sedimentary exhalative deposits, are ore deposits formed when hydrothermal fluids enter a water reservoir, such as an ocean, and discharge minerals. Geology validates the value of SEDEX deposits, which have proven to be a major source of high grade minerals including copper, silver, gold and tungsten, as well as being the world’s single most important source of both lead and zinc.
The value of high grade SEDEX deposits is further crystallized by looking at the increasing value of the underlying minerals. The intrinsic nature of silver and gold are overshadowed by the current shortage and increased global demand for zinc. Zinc prices have exploded over 60 percent this year, to $1.17 per pound in May 2017 from $0.70 per pound one year ago, and zinc appears to be poised to break even higher due to a projected shortage of about 500,000 tons this year. Zinc is indispensable in building materials, automotive, galvanized steel and the production of batteries.
With the famed Sullivan Mine shut down, attention has now turned to what may become the planet’s next legendary SEDEX deposit. In line with these efforts, Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is ramping up exploration of its Sully Project. Located just 18 miles from Sullivan, the same sedimentary rocks that host Sullivan are present at Sully and could be different environments of the same basin. Paul Ransom, respected geologist and noted Sullivan SEDEX deposit expert, has called the Sully Project, “…the best exploration target of Sullivan Size that I have seen in my (33 year) career.”
So far, drilling efforts at the Sully Project have been deemed a very near miss, and Kootenay Zinc has undertaken the necessary steps to target what may well become the world’s next great SEDEX deposit.
For more information, visit the company’s website at www.KootenayZinc.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
MissionIRNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Engagement of Venture Building Firm Launch Haus, LLC
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its engagement of Launch Haus, LLC, a venture building firm and digital holding company specializing in direct response marketing. Moving forward, Launch Haus is expected to play an “integral part” in directing CIIX’s corporate organization, as well as its planned launch of direct-to-consumer ecommerce and network marketing business divisions. “Launch Haus is the perfect firm to oversee CIIX’s direct response marketing campaign which will include significant direct-to-consumer ecommerce channels such as Amazon and development of the Company’s international network marketing platform as we begin to drive revenues in the coming fiscal year,” Warren Wang, CEO of CIIX, stated in the news release. “We are prepared for rapid domestic and international expansion.” CIIX’s primary goals for Launch Haus center on the development of a customized direct response marketing campaign and a compensation plan that incentivizes rapid growth through recruitment of both entry-level consumers and top-tier distributors. Per this morning’s news release, CIIX is currently on track to “announce an official launch date of its direct selling platform in the coming fiscal year.”
To view the full press release, visit http://dtn.fm/SywL6
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
To view the full press release, visit http://dtn.fm/SywL6
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Monday, June 5, 2017
ChineseInvestors.com, Inc. (CIIX) Presents Obvious Upside
Archaeological research suggests that Cannabis Sativa, the source plant for cannabidiol (CBD) compounds, was one of the first agricultural crops planted by early man near the birth of agriculture some 10,000 to 12,000 years ago. The use of CBD for health benefits extends back several thousand years as well. CBD is one of more than 80 active cannabinoid chemicals in the Cannabis Sativa (marijuana) plant and is a part of the cannabis plant that does not produce euphoria or a “high”. Anecdotally, CBD has long been considered to have a broad range of medical benefits. Now, two major studies released in the last four months have scientifically validated the medicinal efficacy of CBD.
The New England Journal of Medicine just confirmed what thousands have attested to anecdotally for years (http://dtn.fm/0KOsd). The report shows that CBD dramatically reduced the number of convulsive seizures in children with a severe and often fatal epilepsy disorder. “The median frequency of convulsive seizures per month decreased from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with (a) placebo.” The results of the NEJM study follow a sweeping 400-page report released in January by the National Academies of Science, Engineering, and Medicine which covered more than 10,000 scientific studies on marijuana and medicine. The report’s conclusions that marijuana does have legitimate medical uses are supported by scientific studies that show cannabis and cannabinoids are effective at treating chronic pain and that cannabinoid substances were effective for treating chemotherapy-related nausea.
With medical efficacy questions resolved, smart money is now looking for avenues to profit from this explosive new medical market. The Hemp Business Journal (https://www.hempbizjournal.com/) recently projected that the CBD market will grow to a $2.1 billion market in consumer sales by 2020; a 700% increase from 2016 in the U.S. alone. Globally, the growth could be even stronger.
Recently, ChineseInvestors.com (OTCQB: CIIX) has made several interesting announcements highlighting the worldwide growth potential from its investments and commitments in the global cannabis industry. The recent launch of what management identifies as the “world’s first Cannabidiol (CBD) health products online store in the Chinese Language (www.ChineseCBDoil.com)” is a significant milestone for the company and the 2+ billion Chinese speaking people it serves. The company also launched a Chinese language Yelp-style mobile application that contains a location-enabled database of recreational and medical marijuana dispensaries, as well as a platform to review and discuss various cannabis products. ChineseInvestors.com is about to make its mark in the global CBD market.
Historically, ChineseInvestors.com has served as a specialized investment services company providing real-time commentary, analysis, and education-related services in the Chinese language. However, the company’s growth focused, long term quest for value add opportunities led it to stake out a position in the explosive new medical CBD market. With nearly two decades of brand recognition, a current user base of 100,000+ and a target market of nearly two billion Chinese speaking people, ChineseInvestors.com is well positioned to capture more than a fair share of the global Chinese speaking CBD market. Confirming this assumption, SeeThruEquity, a leading independent equity research firm, recently issued an update and increased its price target for CIIX to $3.75, “reflecting potential from the company’s legal cannabis initiatives.” Currently trading near a dollar a share, the upside seems obvious.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
The New England Journal of Medicine just confirmed what thousands have attested to anecdotally for years (http://dtn.fm/0KOsd). The report shows that CBD dramatically reduced the number of convulsive seizures in children with a severe and often fatal epilepsy disorder. “The median frequency of convulsive seizures per month decreased from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with (a) placebo.” The results of the NEJM study follow a sweeping 400-page report released in January by the National Academies of Science, Engineering, and Medicine which covered more than 10,000 scientific studies on marijuana and medicine. The report’s conclusions that marijuana does have legitimate medical uses are supported by scientific studies that show cannabis and cannabinoids are effective at treating chronic pain and that cannabinoid substances were effective for treating chemotherapy-related nausea.
With medical efficacy questions resolved, smart money is now looking for avenues to profit from this explosive new medical market. The Hemp Business Journal (https://www.hempbizjournal.com/) recently projected that the CBD market will grow to a $2.1 billion market in consumer sales by 2020; a 700% increase from 2016 in the U.S. alone. Globally, the growth could be even stronger.
Recently, ChineseInvestors.com (OTCQB: CIIX) has made several interesting announcements highlighting the worldwide growth potential from its investments and commitments in the global cannabis industry. The recent launch of what management identifies as the “world’s first Cannabidiol (CBD) health products online store in the Chinese Language (www.ChineseCBDoil.com)” is a significant milestone for the company and the 2+ billion Chinese speaking people it serves. The company also launched a Chinese language Yelp-style mobile application that contains a location-enabled database of recreational and medical marijuana dispensaries, as well as a platform to review and discuss various cannabis products. ChineseInvestors.com is about to make its mark in the global CBD market.
Historically, ChineseInvestors.com has served as a specialized investment services company providing real-time commentary, analysis, and education-related services in the Chinese language. However, the company’s growth focused, long term quest for value add opportunities led it to stake out a position in the explosive new medical CBD market. With nearly two decades of brand recognition, a current user base of 100,000+ and a target market of nearly two billion Chinese speaking people, ChineseInvestors.com is well positioned to capture more than a fair share of the global Chinese speaking CBD market. Confirming this assumption, SeeThruEquity, a leading independent equity research firm, recently issued an update and increased its price target for CIIX to $3.75, “reflecting potential from the company’s legal cannabis initiatives.” Currently trading near a dollar a share, the upside seems obvious.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)